Articles By Anuja Singh
Is Aidoc Driving Clinical Adoption of AI in Medical Imaging as Health Systems Scale…
Executive Summary Aidoc, a pioneer in AI-assisted radiology and diagnostic workflow automation, continues to expand its footprint in…
ByIs Viz.ai Transforming Medical Diagnostics and Acute Care with AI, Driving Global Adoption and…
Executive Summary Viz.ai, a leader in AI‑enabled clinical diagnostics and workflow orchestration, is reshaping how acute care conditions—especially…
Is NVIDIA Powering the AI Revolution in Medical Diagnostics as Healthcare Partners Commit to…
Executive Summary NVIDIA, the global leader in accelerated computing and AI infrastructure, is increasingly at the core of…
Did NVIDIA Become the Central AI Catalyst for Biopharma in 2025—And Which Players Benefited…
2025 marked a pivotal year for artificial intelligence in biopharma. As life sciences companies moved beyond isolated AI…
Which AI Biopharma Startups Truly Won in 2025—And How Did NVIDIA, Big Pharma Collaborations,…
Executive Perspective 2025 marked a decisive shift for AI biopharma startups—from experimental promise to measurable strategic impact. Success…
Is Nabla Bio Redefining AI-Driven Protein Engineering as Pharma Seeks Faster Paths to Biologics…
Executive Summary Nabla Bio is emerging as a next-generation AI biotech focused on computationally driven protein and antibody…
Is Aidoc Driving Clinical Adoption of AI in Medical Imaging as Health Systems Scale…
Executive Summary Aidoc, a pioneer in AI-assisted radiology and diagnostic workflow automation, continues to expand its footprint in…
Is Viz.ai Transforming Medical Diagnostics and Acute Care with AI, Driving Global Adoption and…
Executive Summary Viz.ai, a leader in AI‑enabled clinical diagnostics and workflow orchestration, is reshaping how acute care conditions—especially…
Is NVIDIA Powering the AI Revolution in Medical Diagnostics as Healthcare Partners Commit to…
Executive Summary NVIDIA, the global leader in accelerated computing and AI infrastructure, is increasingly at the core of…
Did NVIDIA Become the Central AI Catalyst for Biopharma in 2025—And Which Players Benefited…
2025 marked a pivotal year for artificial intelligence in biopharma. As life sciences companies moved beyond isolated AI…
Which AI Biopharma Startups Truly Won in 2025—And How Did NVIDIA, Big Pharma Collaborations,…
Executive Perspective 2025 marked a decisive shift for AI biopharma startups—from experimental promise to measurable strategic impact. Success…
Is Nabla Bio Redefining AI-Driven Protein Engineering as Pharma Seeks Faster Paths to Biologics…
Executive Summary Nabla Bio is emerging as a next-generation AI biotech focused on computationally driven protein and antibody…